Devil's Claw for Anti-Inflammatory

Research suggests that Devil's Claw possesses anti-inflammatory properties, supported by a range of laboratory studies, animal experiments, and several reviews of clinical evidence, with findings generally indicating that its iridoid glycosides — particularly harpagoside — can suppress key inflammatory signaling proteins such as TNF-α, IL-1β, and IL-6. Studies indicate that whole plant extracts tend to outperform isolated compounds, and at least one metabolic study found that biological processing did not diminish, and may even enhance, these effects. However, the overall evidence base is mixed and limited: a 1983 preclinical study found no measurable anti-inflammatory activity, the number of new studies has declined in recent years according to a 2022 review, and the clinical trial record remains thin — with most human-focused reviews noting that the existing trials are too small and methodologically inconsistent to draw firm conclusions. The research landscape currently consists primarily of in vitro studies, animal models, and narrative reviews rather than large, rigorous randomized controlled trials, meaning that while the laboratory rationale is reasonably well established, whether these effects reliably translate to meaningful outcomes in humans remains an open question.